Minoryx Therapeutics
Barcelona
About Minoryx Therapeutics
Minoryx, they are committed to finding innovative treatments for life threatening rare diseases. They focus on pediatric diseases and they are currently working on treatments for neurometabolic diseases of genetic origin.Minoryx develops a new generation of small molecule drugs known as pharmacological chaperones, which offer the most promising approach to the treatment of genetic diseases severely affecting the central nervous system. As a complementary approach, Minoryx is also involved in repositioning-based projects.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $175.4M
- Funding stage: Late Stage Venture
- Last round: Grant (Jul 2025)
- Website: minoryx.com
- Phone: 34 93 702 19 75
Industries & Categories
Biotechnology, Genetics, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/minoryx-therapeutics-43081 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.